Stark figures show disappearance of generics from Europe

As many as 26% of all generics have disappeared across Europe over the past decade, according to trade group Medicines for Europe.

The group represents generic and biosimilar drug manufacturers in Europe and is concerned that too many of these medicines that were available on the market just 10 years ago, are disappearing, and that supply is too consolidated.

This rapid decline and consolidation, higher in certain therapy areas such as cancer care and antibiotics, risks creating more shortages and threatens vital access for patients, Medicines for Europe says.